18,99 €
inkl. MwSt.

Versandfertig in über 4 Wochen
Melden Sie sich für den Produktalarm an, um über die Verfügbarkeit des Produkts informiert zu werden.

  • Broschiertes Buch

The suicide of a woman being treated for depression initiates a cascade of events leading to a rash of unexplained deaths. When FDA epidemiologist Carrie Hediger inadvertently uncovers these deaths, sheâ s left with pressing questions: Are these deaths connected? What do they have in common? Are more deaths to come? Carrie and her team buck the system to find the answer.

Produktbeschreibung
The suicide of a woman being treated for depression initiates a cascade of events leading to a rash of unexplained deaths. When FDA epidemiologist Carrie Hediger inadvertently uncovers these deaths, sheâ s left with pressing questions: Are these deaths connected? What do they have in common? Are more deaths to come? Carrie and her team buck the system to find the answer.
Autorenporträt
Elizabeth Reed Aden, PhD earned her doctorate in bio-medical anthropology from the University of Pennsylvania. After conducting extensive epidemiology and serology studies and teaching as an Assistant Professor at the University of Illinois, Urbana-Champaign, she began career in the pharmaceutical industry, where she rose to be Senior Vice President for Global Pharmaceutical Strategy at a major Swiss pharmaceutical company. After leaving Big Pharma, she held leadership positions in various biotechnology companies, founded and co-founded biotech companies, consulted for a wide range of clients, and served on Boards of Directors. Since 2017, she has brought multiple previously unpublished cozy murder mysteries written by her godmother, Eunice Mays Boyd, to print, among them Dune House, Slay Bells, and A Vacation to Kill For. The Goldilocks Genome is Elizabeth’s debut medical thriller. She is currently working on a memoir, Hepatitis Beach, which she hopes to have published by 2025. She lives in Berkeley, California.